Managing anticoagulant therapies using innovative thrombin generation assays

P Soskin, M-L Wiesel, J-M Mossard, L Grunebaum, R Arbogast, G Roul, P Bareiss, A Sacrez, F Cherrier, J-P Cazenave, POTENTIAL THROMBOGENICITY OF CORONARY ANGIOPLASTY COMPARED WITH CORONARY ANGIOGRAPHY Blood Coagulation & Fibrinolysis. ,vol. 5, pp. 965- 966 ,(1994) , 10.1097/00001721-199412000-00014

Bruce Furie, Barbara C. Furie, Mechanisms of Thrombus Formation The New England Journal of Medicine. ,vol. 359, pp. 938- 949 ,(2008) , 10.1056/NEJMRA0801082

G. A. F. Nicolaes, M. C. L. G. D. Thomassen, G. Tans, J. Rosing, H. C. Hemker, Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals Blood Coagulation & Fibrinolysis. ,vol. 8, pp. 28- 38 ,(1997) , 10.1097/00001721-199701000-00006

O. J. A. T. Meuwissen, A. C. Vervoorn, O. Cohen, F. L. J. Jordan, F. A. Nelemans, A double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Medica Scandinavica. ,vol. 182, pp. 549- 566 ,(2009) , 10.1111/J.0954-6820.1969.TB01488.X

Victor Serebruany, Yanti Sani, Donald Lynch, Alex Schevchuck, Stan Svetlov, Alan Fong, Lionel Thevathasan, Dan Hanley, Effects of dabigatran in vitro on thrombin biomarkers by Calibrated Automated Thrombography in patients after ischemic stroke Journal of Thrombosis and Thrombolysis. ,vol. 33, pp. 22- 27 ,(2012) , 10.1007/S11239-011-0654-X

Michael P. Gulseth, Jessica Michaud, Edith A. Nutescu, Rivaroxaban: An oral direct inhibitor of factor Xa American Journal of Health-system Pharmacy. ,vol. 65, pp. 1520- 1529 ,(2008) , 10.2146/AJHP070624

R. Al Dieri, S. Beguin, H. C. Hemker, The ionic contrast medium ioxaglate interferes with thrombin-mediated feedback activation of factor V, factor VIII and platelets. Journal of Thrombosis and Haemostasis. ,vol. 1, pp. 269- 274 ,(2003) , 10.1046/J.1538-7836.2003.00026.X

T. Koster, J.P. Vandenbroucke, F.R. Rosendaal, E. Briët, F.R. Rosendaal, A.D. Blann, Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis The Lancet. ,vol. 345, pp. 152- 155 ,(1995) , 10.1016/S0140-6736(95)90166-3

B. Sørensen, P. Johansen, K. Christiansen, M. Woelke, J. Ingerslev, Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. Journal of Thrombosis and Haemostasis. ,vol. 1, pp. 551- 558 ,(2003) , 10.1046/J.1538-7836.2003.00075.X

A. Ascani, A. Iorio, G. Agnelli, Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation. Blood Coagulation & Fibrinolysis. ,vol. 10, pp. 291- 295 ,(1999) , 10.1097/00001721-199907000-00011